Details for New Drug Application (NDA): 202230
✉ Email this page to a colleague
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 202230
Tradename: | LOSARTAN POTASSIUM |
Applicant: | Macleods Pharms Ltd |
Ingredient: | losartan potassium |
Patents: | 0 |
Pharmacology for NDA: 202230
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 202230
Suppliers and Packaging for NDA: 202230
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 202230 | ANDA | Macleods Pharmaceuticals Limited | 33342-044 | 33342-044-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-044-07) |
LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 202230 | ANDA | Macleods Pharmaceuticals Limited | 33342-044 | 33342-044-10 | 90 TABLET, FILM COATED in 1 BOTTLE (33342-044-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | May 30, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | May 30, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | May 30, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription